Cresset Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,583
| Closed | -$213K | – | 2072 |
|
|
2024
Q2 | $213K | Sell |
2,583
-69
| -3% | -$5.68K | ﹤0.01% | 1832 |
|
|
2024
Q1 | $232K | Sell |
2,652
-1,898
| -42% | -$166K | ﹤0.01% | 1681 |
|
|
2023
Q4 | $439K | Buy |
4,550
+942
| +26% | +$90.8K | ﹤0.01% | 1269 |
|
|
2023
Q3 | $319K | Buy |
3,608
+101
| +3% | +$8.94K | ﹤0.01% | 1380 |
|
|
2023
Q2 | $304K | Buy |
+3,507
| New | +$304K | ﹤0.01% | 1380 |
|
|
2022
Q1 | – | Sell |
-2,996
| Closed | -$265K | – | 1009 |
|
|
2021
Q4 | $265K | Buy |
+2,996
| New | +$265K | ﹤0.01% | 929 |
|
|
2019
Q2 | – | Sell |
-208
| Closed | -$18K | – | 628 |
|
|
2019
Q1 | $18K | Buy |
208
+75
| +56% | +$6.49K | ﹤0.01% | 1036 |
|
|
2018
Q4 | $11K | Buy |
+133
| New | +$11K | ﹤0.01% | 830 |
|